Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906667 · ClinicalTrials.gov registry record · Early Phase 1
Sharing History Through Active Reminiscence and Photo-imagery - With MCI
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 23
- Enrollment target
NCT05906667: Completed Early Phase 1 study, sponsored by Oregon Health and Science University.
NCT05906667 is a Early Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 23 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906667, a Early Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The SHARP-MCI study tests impact of walking and social reminiscence on cognitive function, blood pressure, and weight among healthy Black Americans and those experiencing mild cognitive impairment (MCI).
Primary Outcome
Pre/post Montreal Cognitive Assessment
Interventions
- BEHAVIORAL Sharing History through Active Reminiscence and Photo-imagery (SHARP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-05-24 |
| Est. Completion | 2020-08-30 |
| Phase | Early Phase 1 |
What the finished NCT05906667 record still lists
NCT05906667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 1 intervention - of which Sharing History through Active Reminiscence and Photo-imagery (SHARP) is the first listed.
NCT05906667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05906667 about?
NCT05906667 is a clinical study titled "Sharing History Through Active Reminiscence and Photo-imagery - With MCI". The SHARP-MCI study tests impact of walking and social reminiscence on cognitive function, blood pressure, and weight among healthy Black Americans and those experiencing mild cognitive impairment (MCI).
What is the current status of trial NCT05906667?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 23 participants. The study started on 2017-05-24. Estimated completion is 2020-08-30.
What interventions are being tested in trial NCT05906667?
The interventions under investigation include: Sharing History through Active Reminiscence and Photo-imagery (SHARP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05906667?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05906667's enrollment target sits among peer trials
23 1088th of 2000 higher than 898 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI